EA200870404A1 - Производные азабицикло[3.1.0.]гексила в качестве модуляторов рецепторов допамина d3 - Google Patents

Производные азабицикло[3.1.0.]гексила в качестве модуляторов рецепторов допамина d3

Info

Publication number
EA200870404A1
EA200870404A1 EA200870404A EA200870404A EA200870404A1 EA 200870404 A1 EA200870404 A1 EA 200870404A1 EA 200870404 A EA200870404 A EA 200870404A EA 200870404 A EA200870404 A EA 200870404A EA 200870404 A1 EA200870404 A1 EA 200870404A1
Authority
EA
Eurasian Patent Office
Prior art keywords
group
halogen
cyano
alkoxy
phenyl
Prior art date
Application number
EA200870404A
Other languages
English (en)
Inventor
Барбара Бертани
Джорджо Бонаноми
Анна Мария Капелли
Анна Кеккиа
Романо Ди Фабио
Габриелла Джентиле
Фабрицио Микели
Алессандра Паскарелло
Джованна Тедеско
Сильвия Террени
Original Assignee
Глэксо Груп Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0607892A external-priority patent/GB0607892D0/en
Priority claimed from GB0700363A external-priority patent/GB0700363D0/en
Priority claimed from GB0703404A external-priority patent/GB0703404D0/en
Application filed by Глэксо Груп Лимитед filed Critical Глэксо Груп Лимитед
Publication of EA200870404A1 publication Critical patent/EA200870404A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Настоящее изобретение относится к новым соединениям формулы (I)'или их солям, где G выбирают из группы, состоящей из фенила, 5- или 6-членной моноциклической гетероарильной группы или 8-11-членной гетероарильной бициклической группы; А представляет собой группу p1или группу p2где р представляет собой целое число в интервале от 0 до 5; Rпредставляет собой галоген, гидрокси, циано, Cалкил, галогенCалкил, Cалкокси, галоген Cалкокси, Cалканоил и SF; или соответствует группе R; и если р представляет собой целое число в интервале от 2 до 5, каждые из Rмогут быть одинаковыми или различными; Rпредставляет собой водород или Cалкил; n представляет собой 3, 4, 5 или 6; Rпредставляет собой фрагмент, выбранный из группы, состоящей из изоксазолила, -CH-N-пирролила, 1,1-диоксидо-2-изотиазолидинила, тиенила, тиазолила, пиридила, 2-пирролидинонила, и такие Rгруппы необязательно замещены одним или двумя заместителями, выбранными из галогена, циано, Cалкила, галоген Cалкила, Cалкокси, Cалканоила; Rвыбирают из группы, состоящей из водорода, галогена, гидрокси, циано, Cалкила, Cциклоалкила, галогенCалкила, Cалкокси, галогенCалкокси, Cалканоила и NR'R"; или Rпредставляет собой фенильную группу, 5-14-членную гетероциклическую группу; причем любая из указанных фенильных или гетероциклических групп необязательно замещена 1, 2, 3 или 4 заместителями, выбранными из группы, состоящей из галогена, циано, Cалкила, галогенCалкила, Cалкокси, Cалканоила, галогенCалкокси и SF; Rвыбирают из группы, состоящей из водорода, галогена, гидрокси, циано, Cалкила, Cциклоалкила, галогенCалкила, Cалкокси, галогенCалкокси, Cалканоила и NR'R"; или Rпредставляет собой фенильную группу, 5-14-членную гетероциклическую группу; и любая из указанных фенильных или гетероциклических групп
EA200870404A 2006-04-03 2007-03-30 Производные азабицикло[3.1.0.]гексила в качестве модуляторов рецепторов допамина d3 EA200870404A1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0607892A GB0607892D0 (en) 2006-04-03 2006-04-03 Novel compounds
GB0700363A GB0700363D0 (en) 2007-01-09 2007-01-09 Novel compounds
GB0703404A GB0703404D0 (en) 2007-02-21 2007-02-21 Novel compounds
PCT/EP2007/053074 WO2007113232A1 (en) 2006-04-03 2007-03-30 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors

Publications (1)

Publication Number Publication Date
EA200870404A1 true EA200870404A1 (ru) 2009-04-28

Family

ID=38283980

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200870404A EA200870404A1 (ru) 2006-04-03 2007-03-30 Производные азабицикло[3.1.0.]гексила в качестве модуляторов рецепторов допамина d3

Country Status (17)

Country Link
US (1) US7727988B2 (ru)
EP (1) EP2007750B1 (ru)
JP (1) JP5189074B2 (ru)
KR (1) KR20080109063A (ru)
AR (1) AR060237A1 (ru)
AU (1) AU2007233715A1 (ru)
BR (1) BRPI0709660A2 (ru)
CA (1) CA2648087A1 (ru)
CR (1) CR10346A (ru)
EA (1) EA200870404A1 (ru)
ES (1) ES2434337T3 (ru)
IL (1) IL194385A0 (ru)
MA (1) MA30355B1 (ru)
MX (1) MX2008012875A (ru)
PE (1) PE20071152A1 (ru)
TW (1) TW200815404A (ru)
WO (1) WO2007113232A1 (ru)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2060570E (pt) * 2004-02-23 2012-05-07 Glaxo Group Ltd Derivados de azabiciclo(3.1.0)-hexano úteis como moduladores dos receptores d3 da dopamina
GB0507602D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0507601D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
ATE484502T1 (de) * 2005-06-14 2010-10-15 Glaxo Group Ltd Neue verbindungen
GB0512099D0 (en) * 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
EP1919908B1 (en) * 2005-08-22 2010-11-10 Glaxo Group Limited Triazole derivatives as modulators of dopamine d3 receptors
GB0517175D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0517193D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Novel use
GB0517191D0 (en) 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0517187D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
US8163927B2 (en) * 2006-04-03 2012-04-24 Glaxo Group Limited Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors
WO2007113260A1 (en) * 2006-04-03 2007-10-11 Glaxo Group Limited Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
GB0719235D0 (en) * 2007-10-02 2007-11-14 Glaxo Group Ltd Novel compounds
CN102803224A (zh) 2009-06-26 2012-11-28 万能药生物有限公司 新的氮杂双环己烷类化合物
JP2013526507A (ja) 2010-05-12 2013-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用
MX2015007921A (es) * 2012-12-21 2016-03-03 Zenith Epigenetics Corp Compuestos heterociclicos novedosos como inhibidores de bromodominio.
WO2015002754A2 (en) 2013-06-21 2015-01-08 Zenith Epigenetics Corp. Novel bicyclic bromodomain inhibitors
WO2015004534A2 (en) 2013-06-21 2015-01-15 Zenith Epigenetics Corp. Novel substituted bicyclic compounds as bromodomain inhibitors
US9855271B2 (en) 2013-07-31 2018-01-02 Zenith Epigenetics Ltd. Quinazolinones as bromodomain inhibitors
EP3227281A4 (en) 2014-12-01 2018-05-30 Zenith Epigenetics Ltd. Substituted pyridinones as bromodomain inhibitors
CA2966303A1 (en) 2014-12-01 2016-06-09 Zenith Epigenetics Ltd. Substituted pyridines as bromodomain inhibitors
JP2017537946A (ja) 2014-12-11 2017-12-21 ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． ブロモドメイン阻害剤としての置換複素環
CA2966450A1 (en) 2014-12-17 2016-06-23 Olesya KHARENKO Inhibitors of bromodomains
WO2019146740A1 (ja) 2018-01-26 2019-08-01 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する環式化合物
TWI702954B (zh) 2018-03-01 2020-09-01 美商美國禮來大藥廠 Cd73抑制劑
WO2022121914A1 (zh) * 2020-12-10 2022-06-16 上海翰森生物医药科技有限公司 氧代氮环类衍生物调节剂、其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204284B1 (en) 1991-12-20 2001-03-20 American Cyanamid Company Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies
DE4338396A1 (de) 1993-11-10 1995-05-11 Basf Ag N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
DE10311065A1 (de) 2003-03-13 2004-09-23 Abbott Gmbh & Co. Kg Pyrimidin-2-on-Verbindungen und ihre therapeutische Verwendung
PT2060570E (pt) * 2004-02-23 2012-05-07 Glaxo Group Ltd Derivados de azabiciclo(3.1.0)-hexano úteis como moduladores dos receptores d3 da dopamina
DE102004027359A1 (de) * 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyridin-2-onverbindungen und deren Verwendung
DE102004061593A1 (de) * 2004-12-21 2006-06-22 Abbott Gmbh & Co. Kg Substituierte N-heterocyclische Verbindungen und ihre therapeutische Verwendung
GB0507602D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0512099D0 (en) 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
GB0517191D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
WO2007113260A1 (en) 2006-04-03 2007-10-11 Glaxo Group Limited Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
US8163927B2 (en) 2006-04-03 2012-04-24 Glaxo Group Limited Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors

Also Published As

Publication number Publication date
TW200815404A (en) 2008-04-01
MA30355B1 (fr) 2009-04-01
AU2007233715A1 (en) 2007-10-11
WO2007113232A1 (en) 2007-10-11
JP2009532424A (ja) 2009-09-10
JP5189074B2 (ja) 2013-04-24
CA2648087A1 (en) 2007-10-11
KR20080109063A (ko) 2008-12-16
MX2008012875A (es) 2008-10-13
EP2007750B1 (en) 2013-08-21
IL194385A0 (en) 2009-08-03
AR060237A1 (es) 2008-06-04
US7727988B2 (en) 2010-06-01
CR10346A (es) 2008-10-29
EP2007750A1 (en) 2008-12-31
US20070249642A1 (en) 2007-10-25
ES2434337T3 (es) 2013-12-16
BRPI0709660A2 (pt) 2011-07-19
PE20071152A1 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
EA200870404A1 (ru) Производные азабицикло[3.1.0.]гексила в качестве модуляторов рецепторов допамина d3
ECSP045359A (es) Isoxazolinas 5 metiloximetil sustituidas por 3-heteroarilo utilizadas con herbicidas
MY152805A (en) Benzazepine derivatives useful as vasopressin antagonists
AR040546A1 (es) Derivados de la 1-h- pirrolidin -2,4- diona espirociclicos, cis- alcoxisubstituidos
EA201070782A1 (ru) Производные оксадиазола, активные в отношении сфингозин-1-фосфата(sip)
PE20160608A1 (es) Compuestos de quinolina selectivamente sustituida
EA200701779A1 (ru) Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии
EA201000101A1 (ru) Производные пиримидина 934
EA201100189A1 (ru) Гетероарильные производные в качестве ингибиторов dgat1
MX2013002558A (es) Derivado de imidazol de heteroanillo fusionado que tiene efecto de activacion de proteina cinasa activada por monofosfato de adenosina (amk).
UY31940A (es) Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
EA201070839A1 (ru) Новые производные ацилцианопирролидинов
AR061134A1 (es) Derivados de tioxantina
AR037901A1 (es) Beta-amino-alfa-cianoacrilatos
EA201101566A1 (ru) Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ
NO20055921L (no) Heterocykliske metylsulfonderivater
EA200802052A1 (ru) 2-(пиридин-2-ил)-пиримидины в качестве фунгицидов
EA200970266A1 (ru) Азабициклические соединения в качестве ингибиторов повторного поглощения моноаминов
RU2009105823A (ru) Производные пиримидина и их применение в качестве пестицидов
PH12014502663A1 (en) Aromatic heterocyclic derivative and pharmaceutical
AR083861A1 (es) OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
AR057558A1 (es) Compuestos de cinolincarboxamida y composicion farmaceutica
NZ719465A (en) Quinoline derivatives as bromodomain inhibitors
AR024219A1 (es) COMPUESTOS DE QUINOLONAS 2-(NH- U O-SUSTITUIDAS) UTILES COMO INHIBIDORES DE LA METIONIL t-RNA SINTETASA (MRS) COMPOSICIONES FARMACEUTICAS FORMULADAS CONDICHOS COMPUESTOS; PROCEDIMIENTO PARA SU PREPARACION Y USO DE DICHOS COMPUESTOS PARA PREPARAR MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIONES BACTER